Skip to main content

Sardano Joseph C's Form 4/A amendment

Amended

Sensus Healthcare, Inc.SRTS · filed Dec 16, 2021

Accession no.
0001415889-21-006035
Filed
Dec 16, 2021
Trade date
Dec 13-14, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Dec 15, 2021

This filing lists 2 non-derivative transactions. Open-market sales total $133.0K. It was filed 3 days after the trade.

This amendment replaces 0001415889-21-005956 (filed Dec 15, 2021).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sardano Joseph CCIK 0001300111Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 13, 2021Common StockSSaleDisposed−4,603$6.98F2−$32,128.941,501,845Direct
Dec 14, 2021Common StockSSaleDisposed−13,969$7.22F3−$100,856.181,487,876Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.

F2

The sale prices range from $6.78 through $7.40.

Referenced by the price of 1 transaction in Table I.

F3

The sale prices range from $6.86 through $7.46.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)